Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.87 USD | -0.51% | +8.30% | -3.29% |
Evolution of the average Target Price on Amneal Pharmaceuticals, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Amneal Pharmaceuticals, Inc.
Goldman Sachs | |
Barclays | |
Truist Securities | |
Piper Sandler | |
BMO Capital | |
Guggenheim | |
RBC Capital Markets |
EPS Revisions
- Stock Market
- Equities
- AMRX Stock
- Consensus Amneal Pharmaceuticals, Inc.